EGFR and lung carcinoma: In one study, using lung carcinoma cell line, EGFR inhibition did not block STAT3 phosphorylation and growth arrest, suggesting that upstream pathways, such as JAK and IL6 receptor, may play a role in activating STAT3 and contributing to oncogenesis in lung tumors, even with EGFR activation [53].